- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-hexamer
- Ligands
- 12 x MN: MANGANESE (II) ION(Non-covalent)
- 6 x FB6: 6-(dihydroxyboranyl)-2-methyl-L-norleucine(Non-covalent)
FB6.3: 16 residues within 4Å:- Chain A: D.218, H.220, D.222, N.224, P.230, S.231, H.235, G.236, D.276, E.279, D.325, D.327, E.370
- Chain B: H.383
- Ligands: MN.1, MN.2
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:P.230
- Hydrogen bonds: A:N.224, A:S.231, A:D.276, A:D.327
- Water bridges: A:D.222, A:S.231, A:N.233, A:N.233, A:T.339
FB6.6: 16 residues within 4Å:- Chain B: D.218, H.220, D.222, N.224, P.230, S.231, H.235, G.236, D.276, E.279, D.325, D.327, E.370
- Chain C: H.383
- Ligands: MN.4, MN.5
10 PLIP interactions:10 interactions with chain B- Hydrophobic interactions: B:P.230
- Hydrogen bonds: B:N.224, B:S.231, B:D.276, B:D.327
- Water bridges: B:D.222, B:S.231, B:N.233, B:N.233, B:T.339
FB6.9: 16 residues within 4Å:- Chain A: H.383
- Chain C: D.218, H.220, D.222, N.224, P.230, S.231, H.235, G.236, D.276, E.279, D.325, D.327, E.370
- Ligands: MN.7, MN.8
10 PLIP interactions:10 interactions with chain C- Hydrophobic interactions: C:P.230
- Hydrogen bonds: C:N.224, C:S.231, C:D.276, C:D.327
- Water bridges: C:D.222, C:S.231, C:N.233, C:N.233, C:T.339
FB6.12: 16 residues within 4Å:- Chain D: D.218, H.220, D.222, N.224, P.230, S.231, H.235, G.236, D.276, E.279, D.325, D.327, E.370
- Chain E: H.383
- Ligands: MN.10, MN.11
12 PLIP interactions:12 interactions with chain D- Hydrophobic interactions: D:P.230
- Hydrogen bonds: D:N.224, D:S.231, D:D.276, D:D.327
- Water bridges: D:D.222, D:S.231, D:N.233, D:N.233, D:T.339, D:T.339, D:E.370
FB6.15: 16 residues within 4Å:- Chain E: D.218, H.220, D.222, N.224, P.230, S.231, H.235, G.236, D.276, E.279, D.325, D.327, E.370
- Chain F: H.383
- Ligands: MN.13, MN.14
12 PLIP interactions:12 interactions with chain E- Hydrophobic interactions: E:P.230
- Hydrogen bonds: E:N.224, E:S.231, E:D.276, E:D.327
- Water bridges: E:D.222, E:S.231, E:N.233, E:N.233, E:T.339, E:T.339, E:E.370
FB6.18: 16 residues within 4Å:- Chain D: H.383
- Chain F: D.218, H.220, D.222, N.224, P.230, S.231, H.235, G.236, D.276, E.279, D.325, D.327, E.370
- Ligands: MN.16, MN.17
12 PLIP interactions:12 interactions with chain F- Hydrophobic interactions: F:P.230
- Hydrogen bonds: F:N.224, F:S.231, F:D.276, F:D.327
- Water bridges: F:D.222, F:S.231, F:N.233, F:N.233, F:T.339, F:T.339, F:E.370
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ilies, M. et al., Binding of alpha , alpha-disubstituted amino acids to arginase suggests new avenues for inhibitor design. J.Med.Chem. (2011)
- Release Date
- 2011-07-20
- Peptides
- Arginase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-hexamer
- Ligands
- 12 x MN: MANGANESE (II) ION(Non-covalent)
- 6 x FB6: 6-(dihydroxyboranyl)-2-methyl-L-norleucine(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ilies, M. et al., Binding of alpha , alpha-disubstituted amino acids to arginase suggests new avenues for inhibitor design. J.Med.Chem. (2011)
- Release Date
- 2011-07-20
- Peptides
- Arginase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
AE
AF
A